These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4694661)

  • 21. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 22. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemotherapy in the treatment of advanced breast cancer.
    Rosner D; Nemoto T; Dao TL
    J Surg Oncol; 1976; 8(6):465-9. PubMed ID: 994508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperosmolar hyperglycemic nonketotic coma of unusual cause].
    Mas Marfany J; Ramón Soler R; Baxarías Gascón P
    Rev Esp Anestesiol Reanim; 1978 Jul; 25(4):349-56. PubMed ID: 279029
    [No Abstract]   [Full Text] [Related]  

  • 25. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG; Leone BA; Landó O
    Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
    [No Abstract]   [Full Text] [Related]  

  • 27. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
    Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
    Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 30. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
    Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
    Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
    Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
    Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
    Ruffert K
    Zentralbl Chir; 1998; 123 Suppl 5():156-8. PubMed ID: 10063603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
    Marzetti L; Marcellini G; Midulla C
    Clin Ter; 1982 Nov; 103(4):405-9. PubMed ID: 6817959
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sequential combination chemotherapy in metastatic cancer of the breast].
    Leone BA; Rabinovich MG; Strauss E; Arévalo E
    Medicina (B Aires); 1984; 44(1):15-22. PubMed ID: 6549523
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
    Holland JF; Glidewell O; Cooper RG
    Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytostatic therapy of metastasizing breast cancer].
    Schmidt G; Pittner W
    Z Allgemeinmed; 1973 Dec; 49(34):1690-2. PubMed ID: 4207852
    [No Abstract]   [Full Text] [Related]  

  • 39. [Theory and practice of systemic cancer therapy].
    Nagel GA
    Wien Med Wochenschr; 1972 Nov; 122(47):692-6. PubMed ID: 4634241
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurotoxic side effects of cytostatic therapy (author's transl)].
    Strian F; Maurach R
    Fortschr Neurol Psychiatr; 1981 Apr; 49(4):152-63. PubMed ID: 7239402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.